Streetbeat News

Products Services

OPCH

Option Care Health, Inc. (Nasdaq: OPCH) will participate in the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025, in San Francisco. The company will present at 1:30pm PT, and the webcast and presentation materials will be available online.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

OCX

Oncocyte Corp. (NASDAQ: OCX) has announced favorable data from a study on its DetermaCNI™ assay, which shows potential for liquid biopsy of brain tumors.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

ADEA

Adeia Inc. has renewed a multi-year worldwide license agreement with Sharp Corporation for its media intellectual property portfolio. This renewal highlights the continued value and demand for Adeia's patented innovations in the entertainment industry.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

HLF

Herbalife Ltd. will participate in a Water Tower Research fireside chat on December 10, 2024, featuring CFO John DeSimone.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

CHPT

ChargePoint Holdings, Inc. reported its third quarter fiscal year 2025 financial results, highlighting record EV sales and increased network utilization driving demand for more charging infrastructure. The results exceeded expectations.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

DCBO

Docebo Inc. won Gold at the Canadian Marketing Association Awards for its Leaders in Learning series, highlighting its impact in the global learning community.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

AAPL

DELL

MSFT

NTDOY

NVDA

SONY

The Nintendo DS celebrates its 20th anniversary, prompting a discussion on the future of portable gaming. Companies like Nintendo, Apple, Dell, Lenovo, Sony, Microsoft, and Nvidia are key players in this evolving market.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

HPNN

Hop-on, Inc.'s subsidiary, Digitalage, is accelerating the launch of a new platform aimed at transforming the $152 billion news industry and the $400 billion social media sector. The platform will provide advanced tools and analytics for media and reporters.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

CRVS

Corvus Pharmaceuticals has published new biochemistry and preclinical data in the npj Drug Discovery journal, highlighting the potential of ITK inhibition with Soquelitinib as a novel approach to modulate tumor immunity.

Portfolio Pulse from

December 04, 2024 | 9:30 pm

ILMN

Illumina, Inc. will webcast its presentation and Q&A session at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2024. The event will be accessible via Illumina's investor website.

Portfolio Pulse from

December 04, 2024 | 9:30 pm